• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Catalog Number 1500350-38
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Cardiac Arrest (1762); Perforation of Vessels (2135); Cardiac Tamponade (2226); Cardiogenic Shock (2262)
Event Date 07/20/2021
Event Type  Death  
Manufacturer Narrative
The stent remains in patient.The device will not be returned for evaluation.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.Na.
 
Event Description
It was reported that the procedure was to treat the left main (lm) artery and left anterior descending artery (lad).A 3.5x38mm xience sierra stent was implanted in both lesions.Post dilatation with an unspecified device revealed a perforation in the lad and a rupture in the lm.A pericardial puncture was performed and a non-abbott covered stent was deployed at the lad as well as a non-abbott stent at the lm.Patient went into cardiac arrest; however, was recovered.The patient experienced cardiogenic shock and died.There was no clinically significant delay reported.No additional information was provided.
 
Manufacturer Narrative
The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.The reported patient effects of death, perforation, cardiac arrest, shock and tamponade are listed in the xience sierra everolimus eluting coronary stent systems instructions for use as known patient effects of coronary stenting procedures.A conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined; however, the subsequent treatment appears to be related to the operational context of the procedure.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key12326274
MDR Text Key266723488
Report Number2024168-2021-07184
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 10/15/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/24/2023
Device Catalogue Number1500350-38
Device Lot Number0081241
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 07/28/2021
Initial Date FDA Received08/16/2021
Supplement Dates Manufacturer Received10/14/2021
Supplement Dates FDA Received10/15/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
2ND 3.5X38MM XIENCE SIERRA; 2ND 3.5X38MM XIENCE SIERRA
Patient Outcome(s) Death;
-
-